Stock TRA TRAPHACO
Add to a list
To use this feature you must be a member
Log inSign up

Financials Traphaco

Equities

TRA

VN000000TRA8

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
81,600 VND +0.74% Intraday chart for Traphaco -0.49% -8.31%
Apr. 17 Traphaco Joint Stock Company Announces Board Changes CI
Apr. 16 Traphaco Joint Stock Company Provides Consolidated Earnings Guidance for the Year 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 2,507,758 2,967,859 3,780,289 3,689,098 3,689,098 3,382,364
Enterprise Value (EV) 1 2,507,758 2,967,859 3,780,289 3,689,098 3,689,098 3,382,364
P/E ratio 18.5 x 17.1 x - - - -
Yield - - - - - 3.68%
Capitalization / Revenue 1.46 x - 1.74 x 1.54 x 1.61 x 1.32 x
EV / Revenue 1.46 x - 1.74 x 1.54 x 1.61 x 1.32 x
EV / EBITDA - - - - 8.12 x 6.59 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - 2.9 x 2.68 x 2.14 x
Nbr of stocks (in thousands) 41,451 41,451 41,451 41,451 41,451 41,451
Reference price 2 60,500 71,600 91,200 89,000 89,000 81,600
Announcement Date 3/3/20 3/25/21 1/27/22 1/31/23 1/30/24 -
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 1,716,062 - 2,176,276 2,398,918 2,296,644 2,555,000
EBITDA 1 - - - - 454,086 513,000
EBIT 1 - - - - 359,456 410,000
Operating Margin - - - - 15.65% 16.05%
Earnings before Tax (EBT) - - - - - -
Net income - 195,787 - - - -
Net margin - - - - - -
EPS 3,269 4,185 - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - - - 3,000
Announcement Date 3/3/20 3/25/21 1/27/22 1/31/23 1/30/24 -
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - 22.1% 18.8% 19.9%
ROA (Net income/ Total Assets) - - - 15.3% 14% 15.7%
Assets - - - - - -
Book Value Per Share 1 - - - 30,667 33,204 38,076
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/3/20 3/25/21 1/27/22 1/31/23 1/30/24 -
1VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
81,600 VND
Average target price
95,300 VND
Spread / Average Target
+16.79%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TRAPHACO Stock Traphaco
-8.31% 134M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.70% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.42% 234B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.10% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TRA Stock
  4. Financials Traphaco